Sorry - There were no pages found that contain that search phrase.
 |
 |
 |
 |
|
 |
Showing Treatment 1 to 25 of 67 Next 25 |
 |
Location |
 |
Last Updated |
 |
 |
 |
Details |
 |
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) |
 |
Orlando, FL USA |
 |
09/30/2009 |
 |
 |
 |
 |
 |
Details |
 |
A Phase II Safety and Tolerability Study of Avastin When Added to Single-Agent Chemotherapy to Treat Patient With Breast Cancer Metastatic to Brain |
 |
West Palm Beach, FL USA |
 |
06/16/2009 |
 |
 |
 |
Details |
 |
A Feasibility Assessment and a Phase I/II Trial of MLN518 (Tandutinib) for Treatment of Patients with Recurrent Glioblastoma |
 |
Tampa, FL USA |
 |
04/21/2009 |
 |
 |
 |
 |
 |
Details |
 |
Study of a Drug [DCVax®-Brain] to Treat Newly Diagnosed GBM Brain Cancer |
 |
Tampa, FL USA |
 |
03/15/2009 |
 |
 |
 |
Details |
 |
The GLASS-ART Trial: A Phase III Randomized Study of Neuradiab in Combination With External Beam Radiation and Temozolomide Versus External Beam Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme |
 |
Tampa, FL USA |
 |
03/04/2009 |
 |
 |
 |
 |
 |
Details |
 |
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
 |
Jacksonville, FL USA |
 |
01/31/2009 |
 |
 |
 |
Details |
 |
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
 |
Gainsville, FL USA |
 |
01/31/2009 |
 |
 |
 |
 |
 |
Details |
 |
Phase I/II Study of Sorafenib and Temsirolimus (CCI-779) in Patients With Recurrent Glioblastoma |
 |
Jacksonville, FL USA |
 |
10/09/2008 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Tampa, FL USA |
 |
04/11/2008 |
 |
 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Jacksonville, FL USA |
 |
04/11/2008 |
 |
 |
 |
Details |
 |
NTI 0501: An Open-Labeled, Extended-Use of Human Corticotropin-Releasing Factor (hCRF) (Xerecept) Intended for Patients Who Participate in Dexamethasone-Sparing Studies NTI 0302 or NTI 0303 |
 |
Orlando, FL USA |
 |
03/01/2008 |
 |
 |
 |
 |
 |
Details |
 |
NTI 0501: An Open-Labeled, Extended-Use of Human Corticotropin-Releasing Factor (hCRF) (Xerecept) Intended for Patients Who Participate in Dexamethasone-Sparing Studies NTI 0302 or NTI 0303 |
 |
Jacksonville, FL USA |
 |
03/01/2008 |
 |
 |
 |
Details |
 |
Gliogene: Brain Tumor Linkage Study |
 |
Tampa, FL USA |
 |
01/17/2008 |
 |
 |
 |
 |
 |
Details |
 |
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor |
 |
St. Petersburg, FL USA |
 |
08/18/2007 |
 |
 |
 |
Details |
 |
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor |
 |
West Palm Beach, FL USA |
 |
08/18/2007 |
 |
 |
 |
 |
 |
Details |
 |
Phase I and II, Open-Label, Multi-Center Trials of Pazopanib in Combination With Lapatinib in Adult Patients With Relapsed Malignant Glioma |
 |
Tampa, FL USA |
 |
05/01/2007 |
 |
 |
 |
Details |
 |
Phase I/II Study of Intravenous Infusion of Tetra-o-Methyl Nordihydroguaiaretic Acid (EM-1421) in Subjects With Recurrent High Grade Glioma |
 |
Tampa, FL USA |
 |
05/01/2007 |
 |
 |
 |
 |
 |
Details |
 |
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
 |
Jacksonville, FL USA |
 |
05/01/2007 |
 |
 |
 |
Details |
 |
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
 |
Fort Lauderdale, FL USA |
 |
05/01/2007 |
 |
 |
 |
 |
 |
Details |
 |
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
 |
Miami, FL USA |
 |
05/01/2007 |
 |
 |
 |
Details |
 |
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
 |
Jacksonville, FL USA |
 |
05/01/2007 |
 |
 |
 |
 |
 |
Details |
 |
Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer |
 |
Orlando, FL USA |
 |
05/01/2007 |
 |
 |
 |
Details |
 |
Phase III Randomized Study of Radiotherapy Combined With Temozolomide Versus Carmustine in Patients With Anaplastic Astrocytoma or Mixed Gliomas
|
 |
Jacksonville, FL USA |
 |
05/01/2007 |
 |
 |
 |
 |
 |
Details |
 |
Cilengitide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme |
 |
Tampa, FL USA |
 |
05/01/2007 |
 |
 |
 |
Details |
 |
Talampanel, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
|
 |
Tampa, FL USA |
 |
04/29/2007 |
 |
 |
 |
 |
 |